Montelukast reduces grey matter abnormalities and functional deficits in a mouse model of inflammation-induced encephalopathy of prematurity.

Autor: Yates, Abi G.^1,2 (AUTHOR), Kislitsyna, Elena¹ (AUTHOR), Alfonso Martin, Carla¹ (AUTHOR), Zhang, Jiaying¹ (AUTHOR), Sewell, Amy L.¹ (AUTHOR), Goikolea-Vives, Ane³ (AUTHOR), Cai, Valerie³ (AUTHOR), Alkhader, Lama F.¹ (AUTHOR), Skaland, Aleksander¹ (AUTHOR), Hammond, Basil¹ (AUTHOR), Dimitrova, Ralica^1,4 (AUTHOR), Batalle, Dafnis^1,4 (AUTHOR), Fernandes, Cathy^5,6 (AUTHOR), Edwards, A. David¹ (AUTHOR), Gressens, Pierre⁷ (AUTHOR), Thornton, Claire^1,3 (AUTHOR), Stolp, Helen B.^1,3 (AUTHOR) hstolp@rvc.ac.uk

Publikováno v: Journal of Neuroinflammation. 10/29/2022, Vol. 19 Issue 1, p1-16. 16p.